« previous next »
Pages: [1]

Author Topic: European Commission approves Mayzent for active SPMS  (Read 76 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
European Commission approves Mayzent for active SPMS
« on: January 29, 2020, 09:35:32 pm »

From the European Pharmaceutical Review (January 29, 2020), "European Commission Approves Mayzent for [Active] Secondary Progressive Multiple Sclerosis":

https://www.europeanpharmaceuticalreview.com/news/111603/ec-approves-mayzent-for-secondary-progressive-multiple-sclerosis/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
20 Replies
968 Views 		Last post July 09, 2019, 08:59:28 am
by agate
0 Replies
140 Views 		Last post January 26, 2018, 09:46:57 pm
by agate
3 Replies
208 Views 		Last post September 03, 2020, 08:32:19 pm
by agate
0 Replies
35 Views 		Last post December 02, 2020, 03:38:34 pm
by agate
1 Replies
88 Views 		Last post May 06, 2021, 09:04:27 pm
by agate